Grade-A tertiary cardiac surgery centers in Guangzhou, Wuhan and Shanghai — bypass from $12,000–22,000, against a US median patient out-of-pocket of ≈$75,000 (insured patients, 544-hospital study, 2024).

We coordinate two families of open-heart surgery at large public hospitals' cardiac surgery departments: coronary artery bypass grafting (CABG) for multi-vessel coronary artery disease, and heart valve surgery — repair or replacement of the aortic or mitral valve, with or without a combined bypass. These are high-volume procedures at the hospitals we work with, performed with imported and domestically manufactured devices at a fraction of US prices.
China's centralized procurement program has sharply reduced the cost of stents, valves and surgical consumables — public procurement prices are published, and the savings flow through to the total bill.
Left-main or triple-vessel disease where bypass offers a durable option.
Stenosis or regurgitation requiring repair or replacement (mechanical or bioprosthetic valves).
The most common combined procedure we coordinate.
Patients quoted one option at home who want an independent read before deciding.
| Procedure | China (international dept.) | United States (reference) |
|---|---|---|
| Coronary artery bypass (CABG) | $12,000 – 22,000 | ≈ $75,000 median patient out-of-pocket, insured patients · 544-hospital US study, 2024 |
| Single valve replacement | from ≈ $18,000 | $45,000 – 200,000 cash-pay to billed charges |
| Valve + CABG combined | $21,000 – 42,000 | $130,000 – 270,000 median ≈ $182,000 hospitalization charge · 97,955-case US national study |
Coronary bypass outcomes in China's large cardiac centers have converged with US benchmarks — a China–US registry comparison found no significant mortality difference among large teaching hospitals:
| Measure | China (top cardiac centers) | US benchmark |
|---|---|---|
| Isolated CABG — operative mortality | ~1.0 – 1.8% Fuwai Hospital reports below 1% | ~1.5 – 2.0% (Society of Thoracic Surgeons benchmark) |
Across registries: a comparison of the Chinese Cardiac Surgery Registry against the US National Inpatient Sample found no significant in-hospital mortality difference among large teaching hospitals in the 2011–2013 period (published in Circulation: Cardiovascular Quality and Outcomes).
You send angiography, echo and reports; we confirm which departments realistically fit.
Your case is presented to cardiac surgery departments; quotes and plans arrive in writing.
Visa invitation letter, flights and accommodation arranged before you fly.
Surgeon-led admission, operation and post-operative ICU care; interpreter support for your family throughout.
Typical inpatient stay of 1–2 weeks post-surgery, then discharge with English documents where provided.
Anticoagulation and follow-up plan set before you fly home; later medication trips can be coordinated.
Reference ranges for all treatments, side-by-side with US prices.
Knee and hip surgery from $9,000–16,000, implant included.
The six-step process from first inquiry to follow-up, with fee timing.
Then the free case review can start now — we will tell you what to send and which departments to consider.